Skip to main content

Isolation of c-Kit+ Human Amniotic Fluid Stem Cells from Second Trimester

  • Protocol
  • First Online:
Stem Cell Niche

Part of the book series: Methods in Molecular Biology ((MIMB,volume 1035))

Abstract

Amniotic fluid-derived stem (AFS) cells have been described as an appealing source of stem cells because of their (1) fetal, non-embryonic origin, (2) easy access during pregnancy overcoming the ethical issues related both to the use of human embryonic cells and to the postnatal tissue biopsy with donor site morbidity, and (3) their undemanding ability to be expanded. We and others have demonstrated the broad differentiation potential and here we describe the established protocol we developed to obtain c-Kit+ human AFS cells, starting from second trimester amniocentesis samples.

This is a preview of subscription content, log in via an institution to check access.

Access this chapter

Subscribe and save

Springer+ Basic
$34.99 /Month
  • Get 10 units per month
  • Download Article/Chapter or eBook
  • 1 Unit = 1 Article or 1 Chapter
  • Cancel anytime
Subscribe now

Buy Now

Protocol
USD 49.95
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
eBook
USD 84.99
Price excludes VAT (USA)
  • Available as EPUB and PDF
  • Read on any device
  • Instant download
  • Own it forever
Softcover Book
USD 119.00
Price excludes VAT (USA)
  • Compact, lightweight edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info
Hardcover Book
USD 109.99
Price excludes VAT (USA)
  • Durable hardcover edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info

Tax calculation will be finalised at checkout

Purchases are for personal use only

Institutional subscriptions

Similar content being viewed by others

References

  1. Dobreva MP, Pereira PN, Deprest J et al (2010) On the origin of amniotic stem cells: of mice and men. Int J Dev Biol 54(5):761–777

    Article  PubMed  CAS  Google Scholar 

  2. Pozzobon M, Ghionzoli M, de Coppi P (2010) ES, iPS, MSC, and AFS cells. Stem cells exploitation for pediatric surgery: current research and perspective. Pediatr Surg Int 26(1):3–10

    Article  PubMed  Google Scholar 

  3. Prusa AR, Hengstschlager M (2002) Amniotic fluid cells and human stem cell research: a new connection. Med Sci Monit 8(11):RA253–RA257

    PubMed  Google Scholar 

  4. De Coppi P, Bartsch G Jr, Siddiqui MM et al (2007) Isolation of amniotic stem cell lines with potential for therapy. Nat Biotechnol 25(1):100–106

    Article  PubMed  Google Scholar 

  5. De Coppi P, Callegari A, Chiavegato A et al (2007) Amniotic fluid and bone marrow derived mesenchymal stem cells can be converted to smooth muscle cells in the cryo-injured rat bladder and prevent compensatory hypertrophy of surviving smooth muscle cells. J Urol 177(1):369–376

    Article  PubMed  Google Scholar 

  6. Piccoli M, Franzin C, Bertin E et al (2012) Amniotic fluid stem cells restore the muscle cell niche in a HSA-Cre, Smn(F7/F7) mouse model. Stem Cells 30(8):1675–1684

    Article  PubMed  CAS  Google Scholar 

  7. Ditadi A, de Coppi P, Picone O et al (2009) Human and murine amniotic fluid c-Kit+ Lin-cells display hematopoietic activity. Blood 113(17):3953–3960

    Article  PubMed  CAS  Google Scholar 

  8. Cananzi M, Atala A, de Coppi P (2009) Stem cells derived from amniotic fluid: new potentials in regenerative medicine. Reprod Biomed Online 18(Suppl 1):17–27

    Article  PubMed  Google Scholar 

  9. Klein JD, Fauza DO (2011) Amniotic and placental mesenchymal stem cell isolation and culture. Methods Mol Biol 698:75–88

    Article  PubMed  CAS  Google Scholar 

  10. Roubelakis MG, Pappa KI, Bitsika V et al (2007) Molecular and proteomic characterization of human mesenchymal stem cells derived from amniotic fluid: comparison to bone marrow mesenchymal stem cells. Stem Cells Dev 16(6):931–952

    Article  PubMed  CAS  Google Scholar 

  11. Janz Fde L, Debes Ade A, Cavaglieri Rde C et al (2012) Evaluation of distinct freezing methods and cryoprotectants for human amniotic fluid stem cells cryopreservation. J Biomed Biotechnol 2012:649353

    PubMed  Google Scholar 

  12. Kim J, Lee Y, Kim H et al (2007) Human amniotic fluid-derived stem cells have characteristics of multipotent stem cells. Cell Prolif 40(1):75–90

    Article  PubMed  CAS  Google Scholar 

  13. Tsai MS, Hwang SM, Tsai YL et al (2006) Clonal amniotic fluid-derived stem cells express characteristics of both mesenchymal and neural stem cells. Biol Reprod 74(3):545–551

    Article  PubMed  CAS  Google Scholar 

  14. Abumaree M, Al Jumah M, Pace RA et al (2012) Immunosuppressive properties of mesenchymal stem cells. Stem Cell Rev 8(2):375–392

    Article  PubMed  CAS  Google Scholar 

Download references

Author information

Authors and Affiliations

Authors

Editor information

Editors and Affiliations

Rights and permissions

Reprints and permissions

Copyright information

© 2013 Springer Science+Business Media, LLC

About this protocol

Cite this protocol

Pozzobon, M., Piccoli, M., Schiavo, A.A., Atala, A., De Coppi, P. (2013). Isolation of c-Kit+ Human Amniotic Fluid Stem Cells from Second Trimester. In: Turksen, K. (eds) Stem Cell Niche. Methods in Molecular Biology, vol 1035. Humana Press, Totowa, NJ. https://doi.org/10.1007/978-1-62703-508-8_16

Download citation

  • DOI: https://doi.org/10.1007/978-1-62703-508-8_16

  • Published:

  • Publisher Name: Humana Press, Totowa, NJ

  • Print ISBN: 978-1-62703-507-1

  • Online ISBN: 978-1-62703-508-8

  • eBook Packages: Springer Protocols

Publish with us

Policies and ethics